Dublin, July 21, 2017 (GLOBE NEWSWIRE) -- The "3D Cell Cultures: Technologies and Global Markets" report has been added to Research and Markets' offering.

The scope of the report encompasses the major types of 3D cell culture that have been used, as well as the major applications being developed by industry, academic researchers and their commercialization offices, and government agencies.

It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed. Other influential factors such as screening strategies for pharmaceuticals have also been included.

Report Includes

- An overview of the global markets and technologies for 3D cell cultures.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information on 3D technologies, with a focus on representative platforms, including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
- Value-chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or relationship building.
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Relevant patent analysis, including recent activity and a list of key patents.
- Profiles of major players in the industry.

Key Topics Covered:

1: Introduction

- Study Goals and Objectives
- Reasons for Doing the Study
- Scope of Report

2: Summary and Highlights

- New Applications Identified Since 2015 Report
- Changes from 2015 Report

3: Market and Technology Background

- Tissue and Cell Culture
- Tissue
- Cells
- Tissue Culture and Cell Culture Definitions
- Obtaining Cell Cultures
- Cell Types Based on Morphology
- Cell Types Based on Hybridomas
- Cell Culture: Basic Requirements
- Basic Cell Culture Systems
- History and Early Applications

4: Tissue and Cell Culture Systems Landscape

- Large-Scale Manufacture of Biopharmaceuticals and Vaccines
- Small-Scale Adherent to Make Somatic Cells, Stem Cells and Tissues
- Technology Overview by Cell Culture Type
- Adherent Approaches
- Three-dimensional Bioreactors
- Applications in Regenerative Medicine
- Tissue Culture - Early 3D Pioneers
- Revenue Estimate

5: Research Landscape and Products Used in Three-dimensional Cell Culture

- Microplates
- Cellomics Overview
- Two-dimensional Cultures vs. Three-dimensional Cultures
- Basic 3D Cell Culture Variables
- High Throughput Screening (HTS) Applications
- 3D Assay Open Innovation Platform

6: Three-dimensional Technologies and Basic Products

- Microtiter Plates Provide Platform
- Three-dimensional Cell Culture Technologies
- Importance of 2D vs. 3D Systems
- Basic 3D Cell Culture Variables
- Three-dimensional Technology and Products
- Organs and Organoids
- Tissue Engineering in Regenerative Medicine
- Skin Substitutes Industry
- U.S. Regulatory Status of Bioprinted Products
- Organ Transplants
- Acquisitions and Strategic Alliances
- Revenue Summary
- Market Estimate

7: Three-dimensional Models for Cancer

- Cancer at the Cellular Level Overview
- Approaches to Date
- In Vivo (Animal) Testing Standard
- Three-dimensional Requirements
- Three-dimensional Benefits to Cancer Research
- Breast Cancer as a Driver of Three-dimensional Cultures
- Melanoma as a Driver of Three-dimensional Cultures
- Three-dimensional Systems in Cancer Research
- Three-dimensional Engineered Scaffolds
- Learnings from Drug Sensitivity and Resistance
- Cellular Signaling
- Drug Screening
- Cancer Metabolism
- Future Horizons
- Patient-derived Cells
- Evolution of PDX Platforms
- Ex Vivo Models
- Combining Ex Vivo with NGS
- Revenue Forecast

8: Landscape for Toxicology and Drug Safety Testing

- Toxicology Background
- Efficacy of Cosmetics and Cosmeceuticals
- Bioprinting
- Chronic and Repeated Dose Toxicity
- Carcinogenicity and Genotoxicity
- Reproductive and Developmental Toxicity
- Endocrine Disruptor Screening
- Toxicokinetics and ADME
- In Vitro Developments
- Organotypic Models
- Absorption Barrier Models
- Liver Toxicity
- Uniqueness and Complexity of Liver
- Liver as a Key Driver for Three-dimensional Innovation
- In Vitro Liver Applications
- In Vivo Liver Function and Structure
- Liver Metabolism
- Liver In Vitro Models
- Co-Cultures of Hepatocytes and Macrophages
- Three-dimensional Liver Models
- Bioprinted Liver Tissue
- Detected Hepatosphere Structures and Functionality
- Ideal Criteria
- Drug Resistance
- Transporter Studies
- Achieving Heterotypic Cell-cell Contacts
- Summary Learnings
- Unmet Needs and Future Drivers of Innovation
- Morphogen Signaling
- Microfluidics Applications
- Multi-Donor Liver Cells
- Kidney Toxicity Applications
- Future Challenge: Stem-Cell Derived Kidney Cells
- Pancreatic Toxicology Applications
- Cardiovascular Safety Testing of New Drug Candidates
- Revenue Estimate

9: 3D Culture Role in Stem Cells

- Introduction
- Early Learnings
- Embryogenesis
- Three-dimensional Stem Cell Culture Systems
- Controlling Embryoid Body Formation
- Applications
- Status and Drivers
- Fujifilm (Cellular Dynamics Inc.)
- Breakthroughs Resulting from Stem Cells Research
- Revenue Estimate

10: Three-dimensional Next-Generation Outlook

- Overview
- Cancer
- Predictive Toxicology
- Stem Cells for Neuroscience Discovery and Development
- Stem Cells for Cardiovascular Discovery
- Stem Cells for Development of Regenerative Medicine
- Revenue Estimate
- Chapter Appendix: Liver

11: Company Profiles

- 3D Biomatrix Inc.
- 3D Biotek Llc
- 3D Cell Technologies Llc
- 4D Technology
- Abcam
- Akron Biotechnology Llc
- Amsbio Llc
- Agilent Technologies
- Alpco
- Applikon Biotechnology
- Beckman Coulter Life Sciences
- Biogelx Ltd.
- Bioinspired Solutions
- Biotime Inc.
- Biovision Inc.
- Cell Applications Inc.
- Cellink
- Cellspring
- Corning Life Sciences
- Cyprotex Plc
- Cytoo Sa
- EMD Millipore
- Emulate Inc.
- Epithelix Sarl
- GE Healthcare Life Sciences
- Greiner Bio-One
- Hamilton Robotics
- Hubrecht Organoid Technology
- Hurel Corp.
- Insphero AG
- Invitrocue Ltd.
- Kiyatec Inc.
- Lifenet Health
- Mattek Corp.
- Mimetas Inc.
- Mitra Biotech Inc.
- N3D Biosciences Inc.
- National Center For Advancing Translational Sciences (Ncats)
- Organovo
- Perkinelmer
- Plasticell Ltd.
- Pluristem Therapeutics, Inc.
- Poietis SAS
- Promega Corp.
- Qualyst Transporter Solutions Llc.
- Screen Holdings Co. Ltd.
- Solidus Biosciences Inc.
- Stemcell Technologies Inc.
- Stratatech Corp.
- Synvivo Inc.
- Tap Biosystems
- Tecan Group Ltd.
- Thermo Fisher Scientific
- Zen-Bio Inc.

12: Appendix: Patent Analysis

For more information about this report visit https://www.researchandmarkets.com/research/jbczsp/3d_cell_cultures

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Biotechnology